Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 8
Submit an article Journal homepage
485
Views
63
CrossRef citations to date
0
Altmetric
Review

Virus-like particles as universal influenza vaccines

Sang-Moo Kang Center for Inflammation, Immunity & Infection, and Department of Biology, Georgia State University, Atlanta, GA 30303, USA. [email protected]; Center for Inflammation, Immunity & Infection, and Department of Biology, Georgia State University, Atlanta, GA 30303, USA. [email protected]
,
Min-Chul Kim Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA
&
Richard W Compans Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA
Pages 995-1007 | Published online: 09 Jan 2014

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ye Wang, Lei Deng, Sang-Moo Kang & Bao-Zhong Wang. (2018) Universal influenza vaccines: from viruses to nanoparticles. Expert Review of Vaccines 17:11, pages 967-976.
Read now
Vidadi Yusibov, Natasha Kushnir & Stephen J Streatfield. (2015) Advances and challenges in the development and production of effective plant-based influenza vaccines. Expert Review of Vaccines 14:4, pages 519-535.
Read now
Guo-Ping Zhou. (2013) Mission of randomness. Virulence 4:8, pages 669-670.
Read now
Suryaprakash Sambhara & Rino Rappuoli. (2012) Improving influenza vaccines. Expert Review of Vaccines 11:8, pages 871-872.
Read now

Articles from other publishers (59)

Filippo Carboni, Roberta Cozzi, Giacomo Romagnoli, Giovanna Tuscano, Cristiana Balocchi, Giada Buffi, Margherita Bodini, Cecilia Brettoni, Fabiola Giusti, Sara Marchi, Giulia Brogioni, Barbara Brogioni, Paolo Cinelli, Luigia Cappelli, Chiara Nocciolini, Silvia Senesi, Claudia Facciotti, Elisabetta Frigimelica, Monica Fabbrini, Daniela Stranges, Silvana Savino, Domenico Maione, Benjamin Wizel, Immaculada Margarit & Maria Rosaria Romano. (2023) Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles. npj Vaccines 8:1.
Crossref
Bo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, Ki-Hye Kim, Jeeva Subbiah, Yu-Jin Jung, Noopur Bhatnagar, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Periasamy Selvaraj & Sang-Moo Kang. (2023) Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice. Immunity & Ageing 20:1.
Crossref
Jiaojiao Nie, Qingyu Wang, Shenghui Jin, Xin Yao, Lipeng Xu, Yaotian Chang, Fan Ding, Zeyu Li, Lulu Sun, Yuhua Shi & Yaming Shan. (2023) Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus. Nano Research 16:5, pages 7337-7346.
Crossref
Piyush Dey, Akanksha Ahuja, Jaishal Panwar, Poonam Choudhary, Shital Rani, Mandeep Kaur, Akanksha Sharma, Jatinder Kaur, Ashok Kumar Yadav, Vikas Sood, Adukamparai R. Suresh Babu, Sanjay K. Bhadada, Gurpal Singh & Ravi Pratap Barnwal. (2023) Immune Control of Avian Influenza Virus Infection and Its Vaccine Development. Vaccines 11:3, pages 593.
Crossref
Shan Zhao, Xinfeng Han, Yifei Lang, Yue Xie, Zhijie Yang, Qin Zhao, Yiping Wen, Jing Xia, Rui Wu, Xiaobo Huang, Yong Huang, Sanjie Cao, Jingchao Lan, Li Luo & Qigui Yan. (2023) Development and efficacy evaluation of remodeled canine parvovirus-like particles displaying major antigenic epitopes of a giant panda derived canine distemper virus. Frontiers in Microbiology 14.
Crossref
Fei Zhao, Fengwen Xu, Xiaoman Liu, Yamei Hu, Liang Wei, Zhangling Fan, Liming Wang, Yu Huang, Shan Mei, Li Guo, Long Yang, Shan Cen, Jianwei Wang, Chen Liang & Fei Guo. (2022) SERINC5 restricts influenza virus infectivity. PLOS Pathogens 18:10, pages e1010907.
Crossref
Luigia Cappelli, Paolo Cinelli, Fabiola Giusti, Ilaria Ferlenghi, Sabrina Utrio-Lanfaloni, Newton Wahome, Matthew James Bottomley, Domenico Maione & Roberta Cozzi. (2022) Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion. PLOS ONE 17:9, pages e0273322.
Crossref
Vasilis C. Pliasas, Zach Menne, Virginia Aida, Ji-Hang Yin, Maria C. Naskou, Peter J. Neasham, J. Fletcher North, Dylan Wilson, Katharine A. Horzmann, Joshy Jacob, Ioanna Skountzou & Constantinos S. Kyriakis. (2022) A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model. Frontiers in Immunology 13.
Crossref
Maria Arista-Romero, Pietro Delcanale, Silvia Pujals & Lorenzo Albertazzi. (2021) Nanoscale Mapping of Recombinant Viral Proteins: From Cells to Virus-Like Particles. ACS Photonics 9:1, pages 101-109.
Crossref
Vili Lampinen, Suvi Heinimäki, Olli H. Laitinen, Marko Pesu, Minna M. Hankaniemi, Vesna Blazevic & Vesa P. Hytönen. (2021) Modular vaccine platform based on the norovirus-like particle. Journal of Nanobiotechnology 19:1.
Crossref
Thennakoon M. Sampath U. Gunathilake, Yern Chee Ching, Hiroshi Uyama & Cheng Hock Chuah. (2021) Nanotherapeutics for treating coronavirus diseases. Journal of Drug Delivery Science and Technology 64, pages 102634.
Crossref
Etori Aguiar Moreira, Yohei Yamauchi & Patrick Matthias. (2021) How Influenza Virus Uses Host Cell Pathways during Uncoating. Cells 10:7, pages 1722.
Crossref
Jen-Min Huang, Shih-Yun Wang, Mei-Ru Lai, Yu-Kai Tseng, Ya-Hui Chi & Li-Min Huang. (2021) Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity. Vaccine 39:24, pages 3259-3269.
Crossref
Maria Arista-Romero, Silvia Pujals & Lorenzo Albertazzi. (2021) Towards a Quantitative Single Particle Characterization by Super Resolution Microscopy: From Virus Structures to Antivirals Design. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Semmannan Kalaiyarasu, Sandeep Bhatia, Niranjan Mishra, Dhanapal Senthil Kumar, Manoj Kumar, Richa Sood, Katherukamem Rajukumar, Boopathi Ponnusamy, Dhruv Desai & Vijendra Pal Singh. (2021) Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e–HA2 Fusion Protein. Frontiers in Veterinary Science 7.
Crossref
Lucas J. Kerstetter, Stephen Buckley, Carly M. Bliss & Lynda Coughlan. (2021) Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses. Frontiers in Immunology 11.
Crossref
Véronique Gomord, Virginie Stordeur, Anne-Catherine Fitchette, Elizabeth D. Fixman, Guy Tropper, Lorna Garnier, Réjean Desgagnes, Sébastien Viel, Julie Couillard, Guillaume Beauverger, Sylvain Trepout, Brian J. Ward, Ronald van Ree, Loic Faye & Louis-P Vézina. (2020) Design, production and immunomodulatory potency of a novel allergen bioparticle. PLOS ONE 15:12, pages e0242867.
Crossref
Wan-Zhen Zhu, Yi-Chi Wen, Shu-Yi Lin, Ting-Chih Chen & Hui-Wen Chen. (2020) Anti-Influenza Protective Efficacy of a H6 Virus-Like Particle in Chickens. Vaccines 8:3, pages 465.
Crossref
Christopher E. Lopez & Kevin L. Legge. (2020) Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine. Vaccines 8:3, pages 434.
Crossref
Alexander Domnich, Ilaria Manini, Donatella Panatto, Giovanna Elisa Calabrò & Emanuele Montomoli. (2020) Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials. Vaccines 8:2, pages 325.
Crossref
Katrin Reiter, Patricia Pereira Aguilar, Dominik Grammelhofer, Judith Joseph, Petra Steppert & Alois Jungbauer. (2020) Separation of influenza virus‐like particles from baculovirus by polymer‐grafted anion exchanger. Journal of Separation Science 43:12, pages 2270-2278.
Crossref
Hadia Syahirah Abd Raman, Swan Tan, Joseph Thomas August & Asif M. Khan. (2020) Dynamics of Influenza A (H5N1) virus protein sequence diversity. PeerJ 7, pages e7954.
Crossref
Anna Kirsteina, Inara Akopjana, Janis Bogans, Ilva Lieknina, Juris Jansons, Dace Skrastina, Tatjana Kazaka, Kaspars Tars, Irina Isakova-Sivak, Daria Mezhenskaya, Tatiana Kotomina, Victoria Matyushenko, Larisa Rudenko & Andris Kazaks. (2020) Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens. Vaccines 8:2, pages 197.
Crossref
Jhanvi Sharma, Kelly Shepardson, Laura L. Johns, Julia Wellham, John Avera, Benjamin Schwarz, Agnieszka Rynda-Apple & Trevor Douglas. (2020) A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability. ACS Applied Materials & Interfaces 12:16, pages 18211-18224.
Crossref
Joseph R. Plummer & James P. McGettigan. (2019) Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. PLOS Neglected Tropical Diseases 13:11, pages e0007800.
Crossref
Mandy Gebauer, Hans C. Hürlimann, Martina Behrens, Thorsten Wolff & Sven-Erik Behrens. (2019) Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme. Vaccine 37:37, pages 5578-5587.
Crossref
Zeyuan Liu, Shuang Wang, Junshi Zhang, Yashuo Wang, Yunyang Wang, Lina Zhang, Li Zhang, Ling Li, Jing Dong & Bin Wang. (2019) Gastrodin, a traditional Chinese medicine monomer compound, can be used as adjuvant to enhance the immunogenicity of melanoma vaccines. International Immunopharmacology 74, pages 105699.
Crossref
Alexander I. Makarkov, Makan Golizeh, Elizabeth Ruiz-Lancheros, Angelica A. Gopal, Ian N. Costas-Cancelas, Sabrina Chierzi, Stephane Pillet, Nathalie Charland, Nathalie Landry, Isabelle Rouiller, Paul W. Wiseman, Momar Ndao & Brian J. Ward. (2019) Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages. npj Vaccines 4:1.
Crossref
Monique Vogel & Martin F. Bachmann. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens 89 102 .
Yu-Jin Kim, Ki-Hye Kim, Eun-Ju Ko, Min-Chul Kim, Yu-Na Lee, Yu-Jin Jung, Young-Tae Lee, Young-Man Kwon, Jae-Min Song & Sang-Moo Kang. (2018) Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination. Journal of Virology 92:20.
Crossref
Dustin M. McCraw, John R. Gallagher, Udana Torian, Mallory L. Myers, Michael T. Conlon, Neetu M. Gulati & Audray K. Harris. (2018) Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization. Scientific Reports 8:1.
Crossref
Young-Seok Kim, Ahyun Son, Jihoon Kim, Soon Bin Kwon, Myung Hee Kim, Paul Kim, Jieun Kim, Young Ho Byun, Jemin Sung, Jinhee Lee, Ji Eun Yu, Chan Park, Yeon-Sook Kim, Nam-Hyuk Cho, Jun Chang & Baik L. Seong. (2018) Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles. Frontiers in Immunology 9.
Crossref
Xuanwei Ding, Dong Liu, George Booth, Wei Gao & Yuan Lu. (2018) Virus-Like Particle Engineering: From Rational Design to Versatile Applications. Biotechnology Journal 13:5, pages 1700324.
Crossref
Arun Kumar, Trine Sundebo Meldgaard & Sylvie Bertholet. (2018) Novel Platforms for the Development of a Universal Influenza Vaccine. Frontiers in Immunology 9.
Crossref
Mi Qi, Xian-En Zhang, Xianxun Sun, Xiaowei Zhang, Yanfeng Yao, Siling Liu, Ze Chen, Wei Li, Zhiping Zhang, Jianjun Chen & Zongqiang Cui. (2018) Intranasal Nanovaccine Confers Homo- and Hetero-Subtypic Influenza Protection. Small 14:13, pages 1703207.
Crossref
Aleksey Firsov, Irina Tarasenko, Tatiana Mitiouchkina, Lyubov Shaloiko, Oleg Kozlov, Leonid Vinokurov, Ekaterina Rasskazova, Arkadii Murashev, Alexander Vainstein & Sergey Dolgov. (2018) Expression and Immunogenicity of M2e Peptide of Avian Influenza Virus H5N1 Fused to Ricin Toxin B Chain Produced in Duckweed Plants. Frontiers in Chemistry 6.
Crossref
Ji-Rong Yang, Chieh-Yu Cheng, Chih-Yuan Chen, Chao-Hua Lin, Chuan-Yi Kuo, Hsiang-Yi Huang, Fu-Ting Wu, Yu-Chih Yang, Chia-Ying Wu, Ming-Tsan Liu & Pei-Wen Hsiao. (2017) A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk. Antiviral Research 140, pages 62-75.
Crossref
Hotcherl Jeong & Baik Lin Seong. (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. Journal of Microbiology 55:3, pages 220-230.
Crossref
Young-Tae Lee, Eun-Ju Ko, Youri Lee, Yu-Na Lee, Zhen Bian, Yuan Liu & Sang-Moo Kang. (2016) CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus. Journal of Virology 90:15, pages 6746-6758.
Crossref
Tannaz Ramezanli, Krizia Karry, Zheng Zhang, Kishore Shah & Bozena Michniak-Kohn. 2016. Drug Delivery. Drug Delivery 207 226 .
Ji-Rong Yang, Chih-Yuan Chen, Chuan-Yi Kuo, Chieh-Yu Cheng, Min-Shiuh Lee, Ming-Chu Cheng, Yu-Chih Yang, Chia-Ying Wu, Ho-Sheng Wu, Ming-Tsan Liu & Pei-Wen Hsiao. (2016) A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses. Antiviral Research 126, pages 8-17.
Crossref
Nedzad Music, Adrian J. Reber, Min-Chul Kim, Ian A. York & Sang-Moo Kang. (2016) Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets. Vaccine 34:4, pages 466-473.
Crossref
Alemu Tekewe, Natalie K. Connors, Frank Sainsbury, Nani Wibowo, Linda H.L. Lua & Anton P.J. Middelberg. (2015) A rapid and simple screening method to identify conditions for enhanced stability of modular vaccine candidates. Biochemical Engineering Journal 100, pages 50-58.
Crossref
Piergiuseppe Nestola, Cristina Peixoto, Ricardo R. J. S Silva, Paula M. Alves, José P. B. Mota & Manuel J. T. Carrondo. (2015) Improved virus purification processes for vaccines and gene therapy. Biotechnology and Bioengineering 112:5, pages 843-857.
Crossref
Vipin K. Deo, Tatsuya Kato & Enoch Y. Park. (2015) Chimeric Virus-Like Particles Made Using GAG and M1 Capsid Proteins Providing Dual Drug Delivery and Vaccination Platform. Molecular Pharmaceutics 12:3, pages 839-845.
Crossref
Yong Taik Lim. (2015) Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease. Clinical and Experimental Vaccine Research 4:1, pages 54.
Crossref
Katja Höschler & Catherine I Thompson. (2014) Modern twist on a classic formula for influenza vaccination. The Lancet Infectious Diseases 14:12, pages 1165-1166.
Crossref
Hye Suk Hwang, Young-Man Kwon, Jong Seok Lee, Si-Eun Yoo, Yu-Na Lee, Eun-Ju Ko, Min-Chul Kim, Min-Kyoung Cho, Young-Tae Lee, Yu-Jin Jung, Ji-Yun Lee, Jian-Dong Li & Sang-Moo Kang. (2014) Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis. Antiviral Research 110, pages 115-123.
Crossref
Kamran Haq & Janet E McElhaney. (2014) Immunosenescence: influenza vaccination and the elderly. Current Opinion in Immunology 29, pages 38-42.
Crossref
Jennifer Plourde & Kevin Harrod. 2014. Human Respiratory Viral Infections. Human Respiratory Viral Infections 473 494 .
Jae-Keun Park, Dong-Hun Lee, Seong-Su Yuk, Erdene-Ochir Tseren-Ochir, Jung-Hoon Kwon, Jin-Yong Noh, Byoung-Yoon Kim, Soo-Won Choi, Sang-Moo Kang, Joong-Bok Lee, Seung-Yong Park, In-Soo Choi & Chang-Seon Song. (2014) Virus-Like Particle Vaccine Confers Protection against a Lethal Newcastle Disease Virus Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals. Clinical and Vaccine Immunology 21:3, pages 360-365.
Crossref
Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo & Anton P.J. Middelberg. (2014) Bioengineering virus-like particles as vaccines. Biotechnology and Bioengineering 111:3, pages 425-440.
Crossref
Dong-Hun Lee, Jae-Keun Park & Chang-Seon Song. (2014) Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use. Clinical and Experimental Vaccine Research 3:2, pages 133.
Crossref
Young-Tae LeeKi-Hye KimEun-Ju KoYu-Na LeeMin-Chul KimYoung-Man KwonYinghua TangMin-Kyoung ChoYoun-Jeong LeeSang-Moo Kang. (2014) New vaccines against influenza virus. Clinical and Experimental Vaccine Research 3:1, pages 12.
Crossref
Sanjay Kapoor & Kuldeep DhamaSanjay Kapoor & Kuldeep Dhama. 2014. Insight into Influenza Viruses of Animals and Humans. Insight into Influenza Viruses of Animals and Humans 163 216 .
Markus Hilleringmann, Björn Jobst & Barbara C. Baudner. 2014. Molecular Vaccines. Molecular Vaccines 823 837 .
Kazuyoshi KaminakaJun-ichi MatsudaChikateru Nozaki. (2013) Influenza Virus M2e with Additional Cysteine Residues Shows Enhanced Immunogenicity and Protection Against Lethal Virus Challenge. Viral Immunology 26:4, pages 291-295.
Crossref
Marc P. Girard, John S. Tam, Yuri Pervikov & Jacqueline M. Katz. (2013) Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses. Vaccine 31:37, pages 3766-3771.
Crossref
Adolfo García-Sastre & Ignacio Mena. (2013) Novel vaccine strategies against emerging viruses. Current Opinion in Virology 3:2, pages 210-216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.